Hub : Traits :

Hayfever, allergic rhinitis or eczema

763 significantly associated models · 227 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 7686056 9637591 4 1 1.2e-12 8.0e-12 1.0e+00 100 RP5-1115A15.1
2 1 24372971 25768937 1 1 1.7e-07 5.2e-12 1.3e-07 41 CLIC4
3 1 92277843 93942442 1 1 2.9e-07 1.6e-06 6.0e-02 85 EVI5
4 1 151079317 152712747 2 2 4.1e-09 1.8e-19 1.2e-18 5 LINGO4 S100A11
5 1 153225886 155138557 3 2 7.0e-14 5.8e-14 2.1e-02 91 C1orf43 IL6R
6 1 160452218 161885352 4 1 2.5e-09 1.4e-09 1.6e-01 94 PPOX
7 1 166702558 168182443 1 1 2.4e-17 1.6e-18 1.0e+00 100 CD247
8 1 172311679 174328801 2 1 1.0e-11 3.7e-13 8.6e-03 87 TNFSF18
9 2 27971195 29344127 1 1 2.0e-13 2.2e-09 2.5e-01 96 RP11-373D23.3
10 2 29976100 31563885 1 1 9.6e-08 5.1e-07 9.2e-01 100 LCLAT1
11 2 60466491 62123953 8 1 6.4e-10 4.7e-08 2.8e-02 84 AC010733.5
12 2 101994731 103767612 4 5 1.6e-26 1.7e-54 2.0e-06 91 IL18R1 IL18RAP IL1RL2
13 2 113192136 114472260 1 1 5.3e-08 6.0e-07 4.1e-02 83 IL36RN
14 2 143154021 145209076 1 1 2.6e-08 9.9e-12 3.8e-05 63 ARHGAP15
15 2 197134790 200117777 6 1 1.7e-15 1.4e-14 2.0e-03 84 SF3B1
16 2 227979775 229380688 1 1 1.7e-08 4.2e-11 7.2e-06 54 CCL20
17 2 241978472 243048760 8 2 1.2e-19 1.8e-20 2.9e-01 99 AC114730.7 D2HGDH
18 3 120799666 122356172 3 1 2.5e-12 2.2e-12 1.0e+00 100 SLC15A2
19 3 140350567 141867638 1 1 3.0e-09 9.8e-10 1.0e+00 100 ZBTB38
20 3 195746112 197161849 1 1 4.1e-08 3.3e-06 1.1e-04 31 PIGX
21 4 38079294 39824758 5 3 9.3e-62 5.6e-73 4.0e-07 92 TLR1 TLR6
22 4 102736456 104627833 3 2 1.1e-08 9.5e-10 1.0e+00 100 MANBA NFKB1
23 4 122377715 124935698 2 2 1.6e-28 9.6e-30 6.5e-01 100 KIAA1109 SPATA5
24 5 34920257 36848558 5 5 1.3e-18 4.5e-45 9.4e-09 83 CAPSL IL7R SPEF2 UGT3A2
25 5 108927715 111770880 6 9 3.6e-41 8.7e-55 NaN NaN SLC25A46 TMEM232 TSLP WDR36
26 5 130830617 132900729 13 3 2.5e-10 6.3e-11 5.9e-01 99 IRF1 KIF3A SLC22A5
27 5 140298815 142230251 2 2 7.0e-09 1.1e-07 4.7e-01 98 AC008781.7 NDFIP1
28 5 176067604 177426530 2 1 1.4e-07 1.9e-07 1.8e-01 93 RGS14
29 6 25266147 26689223 3 1 6.9e-13 1.2e-12 5.3e-02 93 U91328.19
30 6 33745071 35200350 1 1 1.8e-07 7.8e-09 5.1e-08 11 PACSIN1
31 6 89941356 91704536 1 1 8.3e-12 1.3e-12 5.2e-03 84 BACH2
32 6 134905567 136516257 2 1 5.3e-10 2.5e-10 6.0e-02 91 AHI1
33 7 27171588 28918565 1 1 8.4e-09 2.2e-17 1.3e-11 36 JAZF1
34 7 76254810 77744459 1 1 1.7e-07 1.1e-09 1.1e-03 71 GSAP
35 7 140009905 141413051 1 1 2.7e-07 1.3e-06 5.4e-01 98 MRPS33
36 8 100865242 102261691 1 1 3.4e-07 7.1e-07 1.0e+00 100 GAPDHP62
37 9 5091675 7345304 5 3 8.4e-17 2.7e-18 3.5e-07 66 GLDC RANBP6 UHRF2
38 9 122881960 124487495 6 1 1.2e-13 9.1e-14 1.0e+00 100 TRAF1
39 9 126321003 127872298 2 4 7.4e-10 1.1e-09 1.0e+00 100 NEK6 PSMB7
40 10 5238196 6801162 2 2 2.8e-09 5.1e-23 1.9e-19 17 FBXO18 IL2RA
41 10 103527782 105647095 10 1 1.7e-13 1.0e-11 4.0e-01 98 WBP1L
42 11 64669105 66804095 10 2 6.4e-12 3.3e-17 3.7e-06 70 EFEMP2 OVOL1
43 11 75369353 77069746 4 3 6.2e-36 4.8e-57 1.3e-14 76 LRRC32 PRKRIR RP11-111M22.3
44 11 110721187 112335631 3 1 3.8e-13 2.3e-14 1.0e+00 100 SIK2
45 11 118341649 119751585 1 1 3.2e-07 2.1e-09 4.3e-06 41 NLRX1
46 12 55677395 58222672 7 3 3.5e-18 1.3e-21 3.1e-10 57 GLS2 STAT6 SUOX
47 12 111522000 113036817 2 1 1.0e-07 1.3e-15 1.5e-10 36 ADAM1A
48 12 120502726 122429484 2 1 1.5e-09 3.1e-10 1.0e+00 100 SPPL3
49 12 122713991 124424636 2 1 2.5e-08 2.3e-07 9.3e-01 100 MPHOSPH9
50 13 40440805 41928314 1 1 3.3e-17 4.8e-13 6.7e-03 86 FOXO1
51 13 72661114 74288499 1 1 4.1e-09 4.0e-11 2.3e-05 59 PIBF1
52 14 34820295 36440325 3 1 1.3e-11 1.2e-10 7.4e-02 92 FAM177A1
53 14 102118619 104074810 2 2 1.6e-09 2.8e-11 4.2e-06 52 CINP TRAF3
54 15 40778506 42749023 10 1 3.0e-11 1.6e-12 1.1e-03 79 NDUFAF1
55 15 66662107 68183665 1 1 3.9e-10 2.6e-21 5.1e-13 42 SMAD3
56 15 74488424 75864335 1 1 3.7e-07 4.8e-07 9.1e-02 89 MPI
57 15 89921477 92225560 5 1 2.8e-21 1.1e-19 3.0e-01 99 IQGAP1
58 16 10157081 12138068 7 11 2.6e-27 1.2e-34 NaN NaN CLEC16A DEXI FAM18A RMI2 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5
59 16 28063948 29432712 2 1 6.3e-08 7.3e-06 4.4e-01 97 TUFM
60 17 36710513 39510218 17 3 2.1e-22 7.1e-22 4.7e-01 99 KRT222 ORMDL3 THRA
61 17 39993748 41538783 7 1 9.7e-11 2.4e-08 4.1e-01 98 NAGLU
62 17 42628193 43570226 1 1 1.4e-07 1.3e-09 8.8e-04 70 MAP3K14-AS1
63 18 47857988 49306115 1 1 4.1e-07 5.1e-08 1.0e+00 100 SMAD4
64 18 51100222 52540420 1 1 1.3e-07 7.7e-08 1.0e+00 100 POLI
65 20 61522825 62912463 5 1 7.2e-10 8.2e-10 1.0e-01 93 STMN3
66 22 21075537 22685340 3 1 2.8e-09 2.7e-09 1.0e+00 100 CCDC116

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Alzheimer’s Disease (including proxy) 1.26 1 0 0.0 0.00 1.0e+00 PPOX
Crohns Disease (2017) 4.25 19 13 39.4 0.44 6.1e-02 AC010733.5 BACH2 CCDC116 IRF1 KIAA1109 KIF3A LRRC32 NAGLU NDFIP1 NFKB1 ORMDL3 RP11-111M22.3 RP11-373D23.3 SF3B1 SLC22A5 SMAD3 STMN3 TUFM ZBTB38
Irritable Bowel Disease (IBD) 3.83 20 15 45.5 0.50 2.4e-02 AC010733.5 BACH2 CCDC116 FAM177A1 IRF1 KIAA1109 KRT222 LRRC32 NAGLU NDFIP1 ORMDL3 PRKRIR RGS14 RMI2 RP11-111M22.3 RP11-373D23.3 SLC22A5 SMAD3 STMN3 TUFM
Ulcerative Colitis (UC) 2.50 11 4 12.1 0.65 3.0e-02 AC010733.5 CCDC116 IRF1 KIAA1109 KRT222 LRRC32 NDUFAF1 PRKRIR RGS14 SMAD3 STMN3
Major Depression (MDD) 1.11 1 0 0.0 0.00 1.0e+00 C1orf43
Verbal and Numeric Reasoning (VNR) 0.93 2 1 3.0 0.00 1.0e+00 SUOX TUFM
Breast Cancer 1.75 5 3 9.1 -0.50 3.2e-01 EFEMP2 NAGLU SIK2 TLR1 ZBTB38
Prostate Cancer 1.44 2 0 0.0 0.00 1.0e+00 STMN3 WBP1L
Age at First Birth 1.04 1 0 0.0 0.00 1.0e+00 TRAF3
Body Mass Index (BMI) (2010) 1.21 1 0 0.0 0.00 1.0e+00 TUFM
Crohns Disease (2012) 3.38 12 7 21.2 -0.42 1.7e-01 AC010733.5 CCDC116 IRF1 LRRC32 NAGLU NDFIP1 RP11-373D23.3 SF3B1 SLC22A5 SMAD3 STMN3 TUFM
HbA1C 0.84 1 0 0.0 0.00 1.0e+00 ADAM1A
HDL Cholesterol 1.38 3 2 6.1 0.00 1.0e+00 CCDC116 ORMDL3 PACSIN1
Lupus 2.62 7 3 9.1 0.15 7.2e-01 CCDC116 DEXI FAM18A ORMDL3 RP11-876N24.5 SLC15A2 TRAF3
Primary Biliary Cirrhosis 2.89 5 3 9.1 0.33 5.9e-01 DEXI MANBA NFKB1 ORMDL3 RMI2
Schizophrenia 1.12 3 1 3.0 0.00 1.0e+00 MPHOSPH9 RP5-1115A15.1 SF3B1
Triglycerides 0.90 1 1 3.0 0.00 1.0e+00 RP11-373D23.3
Ulcerative Colitis 2.23 3 2 6.1 0.00 1.0e+00 AC010733.5 IRF1 STMN3
Blood Eosinophil Count 14.71 65 57 172.7 -0.85 6.4e-22 AC114730.7 ADAM1A BACH2 CAPSL CCDC116 CD247 CLEC16A CLIC4 D2HGDH DEXI EFEMP2 FAM177A1 FAM18A FBXO18 FOXO1 GLDC GLS2 IL18R1 IL18RAP IL1RL2 IL2RA IL7R IRF1 KIAA1109 KIF3A KRT222 LCLAT1 LRRC32 MANBA MPHOSPH9 NDFIP1 NDUFAF1 NEK6 ORMDL3 OVOL1 PIBF1 POLI PPOX PRKRIR PSMB7 RANBP6 RGS14 RMI2 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 RP5-1115A15.1 SF3B1 SIK2 SLC22A5 SLC25A46 SMAD3 SMAD4 SPATA5 SPEF2 SPPL3 STAT6 SUOX THRA TLR6 TRAF1 TSLP UGT3A2 UHRF2 WDR36
Blood Platelet Count 2.53 35 28 84.8 -0.25 1.3e-01 ADAM1A AHI1 ARHGAP15 C1orf43 CCDC116 CINP CLIC4 EFEMP2 FOXO1 GLS2 IL6R IRF1 KIF3A LCLAT1 MAP3K14-AS1 MPHOSPH9 NDFIP1 NEK6 NLRX1 ORMDL3 OVOL1 PACSIN1 PSMB7 RMI2 SF3B1 SIK2 SLC15A2 SLC22A5 SPPL3 STAT6 STMN3 TRAF1 TRAF3 TUFM WBP1L
Blood Red Count 1.47 24 15 45.5 -0.05 8.1e-01 ADAM1A AHI1 BACH2 CLIC4 EVI5 FOXO1 GLS2 KRT222 MAP3K14-AS1 MPI NDFIP1 NDUFAF1 NFKB1 ORMDL3 POLI RGS14 SF3B1 SLC15A2 STMN3 SUOX TRAF3 TUFM UHRF2 ZBTB38
Blood White Count 3.84 36 21 63.6 -0.42 8.1e-03 AC010733.5 ADAM1A AHI1 ARHGAP15 BACH2 CAPSL CCDC116 CLEC16A DEXI EFEMP2 EVI5 GSAP IQGAP1 IRF1 KIF3A MAP3K14-AS1 NAGLU NDFIP1 ORMDL3 PACSIN1 PIGX POLI PPOX PSMB7 RGS14 RP11-373D23.3 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 RP5-1115A15.1 SLC22A5 STMN3 THRA TRAF1 TRAF3 WBP1L
Heel T-Score 1.32 12 9 27.3 0.09 7.5e-01 CCDC116 EVI5 IQGAP1 JAZF1 LCLAT1 MPHOSPH9 NEK6 OVOL1 PSMB7 RP5-1115A15.1 SLC15A2 ZBTB38
BMI 1.38 14 8 24.2 0.12 6.6e-01 EFEMP2 EVI5 MANBA MPI NAGLU NEK6 PACSIN1 PSMB7 RP5-1115A15.1 STMN3 SUOX TLR1 TRAF3 TUFM
Height 2.40 32 23 69.7 0.24 1.8e-01 C1orf43 CCDC116 CINP EVI5 GLS2 IL18RAP IL7R IQGAP1 IRF1 JAZF1 KIF3A MANBA MPHOSPH9 MRPS33 NDFIP1 NDUFAF1 NFKB1 OVOL1 PACSIN1 RGS14 RP11-373D23.3 RP5-1115A15.1 SLC22A5 SPEF2 SPPL3 STAT6 THRA TLR6 TUFM UGT3A2 WBP1L ZBTB38
Waist Hip Ratio (WHR) 1.26 12 6 18.2 0.67 9.3e-03 ADAM1A DEXI GSAP MPHOSPH9 NAGLU PACSIN1 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 SIK2 WBP1L ZBTB38
Systolic Blood Pressure 1.52 17 10 30.3 0.21 4.1e-01 ADAM1A CCDC116 CLIC4 EFEMP2 MAP3K14-AS1 MPI NDUFAF1 NEK6 OVOL1 POLI PSMB7 RP11-111M22.3 RP11-373D23.3 RP5-1115A15.1 SIK2 SLC15A2 SMAD3
Smoking Status 1.47 5 1 3.0 -0.14 8.2e-01 ADAM1A RP5-1115A15.1 STMN3 SUOX WBP1L
Allergy or Eczema 26.63 98 95 287.9 -1.00 1.6e-120 AC008781.7 AC010733.5 AC114730.7 ADAM1A AHI1 ARHGAP15 BACH2 C1orf43 CAPSL CCDC116 CD247 CINP CLEC16A CLIC4 D2HGDH DEXI EFEMP2 EVI5 FAM177A1 FAM18A FBXO18 FOXO1 GAPDHP62 GLDC GLS2 GSAP IL18R1 IL18RAP IL1RL2 IL2RA IL36RN IL6R IL7R IQGAP1 IRF1 JAZF1 KIAA1109 KIF3A KRT222 LCLAT1 LINGO4 LRRC32 MANBA MAP3K14-AS1 MPHOSPH9 MPI MRPS33 NAGLU NDFIP1 NDUFAF1 NEK6 NFKB1 ORMDL3 OVOL1 PACSIN1 PIBF1 PIGX POLI PPOX PRKRIR PSMB7 RANBP6 RGS14 RMI2 RP11-111M22.3 RP11-373D23.3 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 RP5-1115A15.1 S100A11 SF3B1 SIK2 SLC15A2 SLC22A5 SLC25A46 SMAD3 SMAD4 SPATA5 SPEF2 SPPL3 STAT6 STMN3 SUOX THRA TLR1 TLR6 TMEM232 TNFSF18 TRAF1 TRAF3 TSLP TUFM UGT3A2 UHRF2 WBP1L WDR36 ZBTB38
Cardiovascular Disease 1.48 10 5 15.2 0.23 5.2e-01 ADAM1A CLIC4 IRF1 KRT222 MPI NDUFAF1 RP11-111M22.3 RP5-1115A15.1 SIK2 SUOX
Hypothyroidism (self reported) 3.17 13 9 27.3 0.43 1.2e-01 AC010733.5 ADAM1A AHI1 BACH2 CD247 FBXO18 NEK6 PSMB7 RP5-1115A15.1 SLC15A2 SUOX TLR1 TRAF1
Respiratory disease 15.28 63 41 124.2 -0.95 1.1e-38 AC008781.7 AC114730.7 AHI1 BACH2 C1orf43 CD247 CLEC16A D2HGDH DEXI EVI5 FAM18A FBXO18 FOXO1 GLDC IL18R1 IL18RAP IL1RL2 IL6R IRF1 JAZF1 KIAA1109 KIF3A KRT222 LINGO4 LRRC32 MAP3K14-AS1 MPHOSPH9 NAGLU NDFIP1 NDUFAF1 NEK6 ORMDL3 POLI PPOX PRKRIR PSMB7 RANBP6 RGS14 RMI2 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 RP5-1115A15.1 S100A11 SIK2 SLC15A2 SLC22A5 SLC25A46 SMAD3 SPATA5 SPEF2 SPPL3 STAT6 STMN3 SUOX THRA TLR1 TMEM232 TNFSF18 TRAF1 TSLP UHRF2 WDR36
Type 2 Diabetes (T2D) 1.11 2 0 0.0 0.00 1.0e+00 ADAM1A C1orf43
Lung FEV1/FVC ratio 1.86 19 10 30.3 0.86 2.4e-06 AC010733.5 AC114730.7 BACH2 C1orf43 D2HGDH EVI5 FOXO1 GLDC IL18R1 IL1RL2 IRF1 RGS14 RP11-396B14.2 RP5-1115A15.1 SLC22A5 SMAD3 SUOX THRA ZBTB38
Lung FVC 1.14 13 5 15.2 0.61 2.8e-02 AHI1 CLEC16A DEXI FAM177A1 LINGO4 MPHOSPH9 MRPS33 ORMDL3 SLC22A5 SPPL3 STMN3 SUOX ZBTB38
Neuroticism 0.87 1 1 3.0 0.00 1.0e+00 RP5-1115A15.1
Chronotype (morning person) 1.56 7 1 3.0 0.39 3.3e-01 EVI5 GLS2 NEK6 PSMB7 RP5-1115A15.1 SF3B1 WDR36
Hair Pigment 0.31 9 5 15.2 -0.43 2.5e-01 JAZF1 MPHOSPH9 NEK6 OVOL1 RP11-373D23.3 RP5-1115A15.1 SUOX TRAF3 ZBTB38
Tanning 0.21 3 0 0.0 0.00 1.0e+00 JAZF1 MPI RP11-373D23.3
Hand grip strength (left) 1.28 4 3 9.1 -0.51 4.9e-01 IRF1 SLC22A5 WBP1L ZBTB38
Number of treatments/medications taken 2.04 5 0 0.0 0.70 1.9e-01 ADAM1A CLEC16A MANBA NDUFAF1 OVOL1
Frequency of depressed mood in last 2 weeks 1.11 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Relative age of first facial hair 1.12 3 1 3.0 0.00 1.0e+00 PIBF1 SPPL3 ZBTB38
Ever used hormone-replacement therapy (HRT) 1.40 2 0 0.0 0.00 1.0e+00 NEK6 PSMB7
Systolic blood pressure, automated reading 1.41 7 3 9.1 -0.05 9.1e-01 MPI NDUFAF1 NEK6 PSMB7 RP5-1115A15.1 SLC15A2 STMN3
Impedance of leg (right) 1.24 8 5 15.2 0.78 2.2e-02 EFEMP2 JAZF1 NAGLU PACSIN1 SF3B1 SUOX TUFM WBP1L
Leg fat-free mass (left) 2.01 15 10 30.3 -0.42 1.2e-01 EFEMP2 FOXO1 IRF1 MPHOSPH9 NAGLU NLRX1 PACSIN1 RP11-373D23.3 SLC22A5 SPPL3 SUOX TRAF3 TUFM U91328.19 ZBTB38
Trunk fat percentage 1.45 8 6 18.2 -0.50 2.0e-01 NAGLU PACSIN1 RP5-1115A15.1 SF3B1 TRAF3 TUFM U91328.19 ZBTB38
Hand grip strength (right) 1.12 4 3 9.1 -0.55 4.5e-01 IRF1 SLC22A5 WBP1L ZBTB38
Current tobacco smoking 1.40 1 0 0.0 0.00 1.0e+00 STMN3
Relative age voice broke 1.17 1 0 0.0 0.00 1.0e+00 SPPL3
Taking other prescription medications 2.87 5 0 0.0 0.83 8.4e-02 ADAM1A D2HGDH IL1RL2 ORMDL3 RP11-876N24.4
Age when periods started (menarche) 1.08 2 0 0.0 0.00 1.0e+00 NFKB1 SUOX
Bilateral oophorectomy (both ovaries removed) 1.22 1 0 0.0 0.00 1.0e+00 PSMB7
Heel bone mineral density (BMD) T-score, automated (left) 1.25 4 1 3.0 0.12 8.8e-01 IQGAP1 OVOL1 RP5-1115A15.1 U91328.19
High blood pressure 1.49 8 4 12.1 -0.20 6.4e-01 ADAM1A MPI NDUFAF1 OVOL1 POLI RP5-1115A15.1 SIK2 SUOX
Medication: Levothyroxine sodium 2.80 7 3 9.1 -0.23 6.2e-01 ADAM1A AHI1 BACH2 FBXO18 PSMB7 SLC15A2 SUOX
Sitting height 2.01 12 9 27.3 0.09 7.7e-01 CCDC116 EVI5 IRF1 MPHOSPH9 NDUFAF1 NFKB1 NLRX1 PACSIN1 RGS14 SLC22A5 WBP1L ZBTB38
Body mass index (BMI) 1.47 11 8 24.2 -0.42 2.0e-01 EFEMP2 EVI5 MANBA MPI NAGLU PACSIN1 RP5-1115A15.1 SUOX TRAF3 TUFM U91328.19
Impedance of leg (left) 1.22 9 5 15.2 0.82 7.4e-03 CCDC116 EFEMP2 JAZF1 NAGLU PACSIN1 S100A11 SF3B1 SUOX TUFM
Leg predicted mass (left) 2.01 16 10 30.3 -0.40 1.2e-01 EFEMP2 FOXO1 IRF1 MPHOSPH9 MPI NAGLU NLRX1 PACSIN1 RP11-373D23.3 SLC22A5 SPPL3 SUOX TRAF3 TUFM U91328.19 ZBTB38
Trunk fat mass 1.70 9 5 15.2 -0.16 6.8e-01 EFEMP2 NAGLU PACSIN1 RP5-1115A15.1 STMN3 TRAF3 TUFM U91328.19 ZBTB38
Waist circumference 1.71 11 8 24.2 -0.54 8.7e-02 FOXO1 MPI NAGLU PACSIN1 RP11-373D23.3 STMN3 SUOX TRAF3 TUFM U91328.19 ZBTB38
Past tobacco smoking 1.27 3 1 3.0 0.00 1.0e+00 ADAM1A GLDC WBP1L
Nervous feelings 0.93 1 0 0.0 0.00 1.0e+00 U91328.19
Hearing difficulty/problems with background noise 1.33 2 0 0.0 0.00 1.0e+00 MPI WBP1L
Hair/balding pattern: Pattern 2 1.06 1 0 0.0 0.00 1.0e+00 CLIC4
Forced vital capacity (FVC) 1.05 7 4 12.1 -0.44 3.2e-01 AHI1 LINGO4 MRPS33 PACSIN1 STMN3 WBP1L ZBTB38
Heel bone mineral density (BMD) T-score, automated (right) 1.40 7 2 6.1 0.04 9.3e-01 IQGAP1 NEK6 OVOL1 PSMB7 RP5-1115A15.1 U91328.19 ZBTB38
Qualifications: None of the above 1.19 3 2 6.1 0.00 1.0e+00 MPHOSPH9 SUOX TUFM
Allergy 25.09 100 85 257.6 -0.99 1.3e-100 AC008781.7 AC010733.5 AC114730.7 ADAM1A AHI1 ARHGAP15 BACH2 C1orf43 CAPSL CCDC116 CCL20 CD247 CINP CLEC16A CLIC4 D2HGDH DEXI EFEMP2 EVI5 FAM177A1 FAM18A FBXO18 FOXO1 GAPDHP62 GLDC GLS2 GSAP IL18R1 IL18RAP IL1RL2 IL2RA IL36RN IL6R IL7R IQGAP1 IRF1 JAZF1 KIAA1109 KIF3A KRT222 LCLAT1 LINGO4 LRRC32 MANBA MAP3K14-AS1 MPHOSPH9 MPI MRPS33 NAGLU NDFIP1 NDUFAF1 NEK6 NFKB1 NLRX1 ORMDL3 OVOL1 PACSIN1 PIGX POLI PPOX PRKRIR PSMB7 RANBP6 RGS14 RMI2 RP11-111M22.3 RP11-373D23.3 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 RP5-1115A15.1 S100A11 SF3B1 SIK2 SLC15A2 SLC22A5 SLC25A46 SMAD3 SMAD4 SPATA5 SPEF2 SPPL3 STAT6 STMN3 SUOX THRA TLR1 TLR6 TMEM232 TNFSF18 TRAF1 TRAF3 TSLP TUFM U91328.19 UGT3A2 UHRF2 WBP1L WDR36 ZBTB38
Diabetes (self-reported) 1.16 1 0 0.0 0.00 1.0e+00 NAGLU
Hayfever/allergic rhinitis (self-reported) 11.67 36 18 54.5 0.98 1.0e-29 AC114730.7 BACH2 CD247 CINP CLEC16A D2HGDH DEXI FAM18A GLDC GLS2 IL18R1 IL18RAP IL1RL2 IL7R IQGAP1 KIAA1109 KRT222 LRRC32 ORMDL3 PPOX RANBP6 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 SF3B1 SLC25A46 SMAD3 SPATA5 SUOX TLR1 TMEM232 TNFSF18 TSLP TUFM U91328.19 WDR36
Medication: Ramipril 1.29 1 0 0.0 0.00 1.0e+00 ADAM1A
Medication: Simvastatin 1.13 1 0 0.0 0.00 1.0e+00 NDUFAF1
Fluid intelligence score 1.07 3 0 0.0 0.00 1.0e+00 MPHOSPH9 SUOX TUFM
Illnesses of siblings 1.39 2 0 0.0 0.00 1.0e+00 ADAM1A TRAF3
Neuroticism score 0.83 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Weight 2.09 13 10 30.3 -0.46 1.1e-01 EFEMP2 FOXO1 MPI NAGLU NLRX1 PACSIN1 RP11-373D23.3 SLC22A5 SUOX TRAF3 TUFM U91328.19 ZBTB38
Impedance of arm (right) 1.79 17 9 27.3 0.50 3.6e-02 EFEMP2 JAZF1 LCLAT1 LRRC32 MANBA NDFIP1 NEK6 NLRX1 ORMDL3 PACSIN1 PSMB7 RP11-373D23.3 SF3B1 SMAD3 SUOX THRA U91328.19
Arm fat percentage (right) 1.31 8 6 18.2 -0.34 4.1e-01 NAGLU NDUFAF1 PACSIN1 RP5-1115A15.1 SUOX TRAF3 TUFM U91328.19
Trunk fat-free mass 2.26 20 11 33.3 -0.17 4.5e-01 EFEMP2 GLS2 IQGAP1 IRF1 MPHOSPH9 NDUFAF1 NEK6 NLRX1 PACSIN1 PSMB7 RP11-373D23.3 SF3B1 SLC22A5 SPPL3 SUOX TRAF3 TUFM U91328.19 WBP1L ZBTB38
Hip circumference 1.84 12 6 18.2 -0.28 3.9e-01 EFEMP2 FOXO1 MPI NLRX1 PACSIN1 RP11-373D23.3 STMN3 SUOX TRAF3 TUFM U91328.19 ZBTB38
Father's age at death 1.60 2 0 0.0 0.00 1.0e+00 MPI SLC22A5
Frequency of tiredness / lethargy in last 2 weeks 1.39 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Hair/balding pattern: Pattern 3 0.96 1 0 0.0 0.00 1.0e+00 CLIC4
Number of live births 1.19 1 0 0.0 0.00 1.0e+00 TUFM
Forced expiratory volume in 1-second (FEV1) 1.09 7 1 3.0 -0.40 3.7e-01 AHI1 LINGO4 PACSIN1 STMN3 SUOX WBP1L ZBTB38
Pulse rate 0.96 1 1 3.0 0.00 1.0e+00 ZBTB38
Qualifications: A levels/AS levels or equivalent 1.00 2 1 3.0 0.00 1.0e+00 MPHOSPH9 SUOX
Mouth/teeth dental problems: Dentures 1.49 3 0 0.0 0.00 1.0e+00 PPOX SF3B1 U91328.19
Asthma 15.80 49 38 115.2 0.95 4.8e-32 AC114730.7 AHI1 BACH2 C1orf43 CD247 CLEC16A D2HGDH DEXI FAM18A GLDC IL18R1 IL18RAP IL1RL2 IRF1 JAZF1 KIAA1109 KIF3A KRT222 LINGO4 LRRC32 NAGLU NDFIP1 NDUFAF1 ORMDL3 POLI PPOX PRKRIR RANBP6 RMI2 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 RP5-1115A15.1 S100A11 SIK2 SLC22A5 SLC25A46 SMAD3 SPPL3 STAT6 STMN3 SUOX THRA TLR1 TMEM232 TNFSF18 TSLP UHRF2 WDR36
Medication: Ibuprofen (e.g. Nurofen) 0.95 1 0 0.0 0.00 1.0e+00 STAT6
Medication: Cholesterol lowering 0.97 1 0 0.0 0.00 1.0e+00 NDUFAF1
Depression (self-reported) 1.09 1 1 3.0 0.00 1.0e+00 RP5-1115A15.1
Forced expiratory volume in 1-second (FEV1), Best measure 1.11 5 2 6.1 -0.48 4.2e-01 AHI1 LINGO4 PACSIN1 SUOX ZBTB38
Pulse wave Arterial Stiffness index 1.40 1 1 3.0 0.00 1.0e+00 ADAM1A
Impedance of arm (left) 1.80 16 9 27.3 0.52 3.4e-02 EFEMP2 JAZF1 LCLAT1 LRRC32 MANBA NEK6 NLRX1 ORMDL3 PACSIN1 PSMB7 RP11-373D23.3 SF3B1 SMAD3 SUOX TRAF3 U91328.19
Arm fat mass (right) 1.58 11 7 21.2 -0.47 1.5e-01 FOXO1 MPI NAGLU NLRX1 PACSIN1 RP5-1115A15.1 SUOX TRAF3 TUFM U91328.19 ZBTB38
Trunk predicted mass 2.28 20 11 33.3 -0.17 4.6e-01 EFEMP2 GLS2 IQGAP1 IRF1 MPHOSPH9 NDUFAF1 NEK6 NLRX1 PACSIN1 PSMB7 RP11-373D23.3 SF3B1 SLC22A5 SPPL3 SUOX TRAF3 TUFM U91328.19 WBP1L ZBTB38
Standing height 2.29 18 15 45.5 -0.08 7.7e-01 CCDC116 EVI5 GLS2 IQGAP1 IRF1 MPHOSPH9 NDUFAF1 NLRX1 PACSIN1 RGS14 RP11-373D23.3 RP5-1115A15.1 SLC22A5 SPPL3 TUFM UHRF2 WBP1L ZBTB38
Breastfed as a baby 1.59 3 0 0.0 0.20 8.0e-01 MPHOSPH9 NEK6 PSMB7
Tense / 'highly strung' 1.06 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Seen doctor (GP) for nerves, anxiety, tension or depression 1.32 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Hair/balding pattern: Pattern 4 1.81 7 4 12.1 0.13 7.7e-01 CLIC4 IQGAP1 MAP3K14-AS1 POLI RP5-1115A15.1 S100A11 ZBTB38
Birth weight of first child 1.46 2 1 3.0 0.00 1.0e+00 SUOX ZBTB38
Qualifications: O levels/GCSEs or equivalent 1.22 1 1 3.0 0.00 1.0e+00 MPHOSPH9
Headache pain in last month 1.39 1 0 0.0 0.00 1.0e+00 SUOX
Medication for cholesterol, blood pressure or diabetes 1.30 2 1 3.0 0.00 1.0e+00 NDUFAF1 SIK2
Gout (self-reported) 1.40 1 1 3.0 0.00 1.0e+00 OVOL1
Hypothyroidism/myxoedema (self-reported) 2.96 10 5 15.2 -0.29 3.9e-01 ADAM1A AHI1 BACH2 CD247 FBXO18 NEK6 PSMB7 RP5-1115A15.1 SLC15A2 SUOX
Medication: Amlodipine 1.27 1 0 0.0 0.00 1.0e+00 OVOL1
Medication: Ventolin 100micrograms inhaler 7.39 21 7 21.2 0.95 9.2e-12 AC114730.7 BACH2 CD247 CLEC16A D2HGDH DEXI FOXO1 GLDC IL18R1 IL18RAP IL1RL2 KIAA1109 LRRC32 NDFIP1 ORMDL3 PRKRIR RANBP6 SMAD3 SUOX THRA TLR1
Birth weight 1.42 4 2 6.1 -0.18 8.2e-01 ADAM1A NFKB1 SIK2 TRAF1
Forced vital capacity (FVC), Best measure 1.02 7 1 3.0 -0.43 3.3e-01 AHI1 LINGO4 MRPS33 PACSIN1 STMN3 WBP1L ZBTB38
Body fat percentage 1.44 9 5 15.2 -0.11 7.8e-01 NAGLU NDUFAF1 PACSIN1 RP5-1115A15.1 STMN3 TRAF3 TUFM U91328.19 ZBTB38
Leg fat percentage (right) 1.47 9 5 15.2 -0.10 7.9e-01 KRT222 MPHOSPH9 NDUFAF1 PACSIN1 RP5-1115A15.1 STMN3 TRAF3 TUFM U91328.19
Arm fat-free mass (right) 2.32 15 14 42.4 -0.25 3.5e-01 EFEMP2 MPHOSPH9 NEK6 NLRX1 PACSIN1 PSMB7 RP11-373D23.3 SF3B1 SLC22A5 SUOX TRAF3 TUFM U91328.19 WBP1L ZBTB38
Comparative body size at age 10 1.33 4 1 3.0 -0.94 5.7e-02 EFEMP2 OVOL1 TUFM U91328.19
Seen a psychiatrist for nerves, anxiety, tension or depression 1.08 1 0 0.0 0.00 1.0e+00 U91328.19
Wheeze or whistling in the chest in last year 6.73 27 16 48.5 0.96 8.6e-19 AC114730.7 BACH2 C1orf43 CD247 CLEC16A D2HGDH DEXI GLDC IL18R1 IL18RAP IL1RL2 KIAA1109 LRRC32 ORMDL3 PRKRIR RMI2 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 SIK2 SLC25A46 SMAD3 STAT6 STMN3 THRA TSLP WDR36
Age at first live birth 1.06 1 0 0.0 0.00 1.0e+00 SUOX
Pulse wave peak to peak time 1.37 1 1 3.0 0.00 1.0e+00 ADAM1A
Shortness of breath walking on level ground 1.26 1 0 0.0 0.00 1.0e+00 LRRC32
Qualifications: College or University degree 1.15 4 3 9.1 0.48 5.2e-01 MPHOSPH9 STMN3 SUOX TUFM
Medication for pain relief, constipation, heartburn 1.23 1 0 0.0 0.00 1.0e+00 MPHOSPH9
Neck or shoulder pain in last month 1.51 4 0 0.0 -0.51 4.9e-01 NEK6 PSMB7 RP5-1115A15.1 SUOX
Medication: Blood pressure 1.45 2 1 3.0 0.00 1.0e+00 ADAM1A SIK2
Migraine (self-reported) 1.33 1 1 3.0 0.00 1.0e+00 STAT6
Medication: Allopurinol 1.20 1 1 3.0 0.00 1.0e+00 OVOL1
Medication: Seretide 50 evohaler 3.63 4 0 0.0 0.15 8.5e-01 AC114730.7 BACH2 D2HGDH SLC22A5
Whole body fat mass 1.68 12 6 18.2 -0.27 4.0e-01 EFEMP2 FOXO1 NAGLU NLRX1 PACSIN1 RP5-1115A15.1 STMN3 SUOX TRAF3 TUFM U91328.19 ZBTB38
Leg fat mass (right) 1.75 12 7 21.2 -0.30 3.4e-01 EFEMP2 NAGLU NLRX1 PACSIN1 RP11-373D23.3 RP5-1115A15.1 STMN3 SUOX TRAF3 TUFM U91328.19 ZBTB38
Arm predicted mass (right) 2.34 17 15 45.5 -0.22 3.7e-01 EFEMP2 MPHOSPH9 MPI NDUFAF1 NEK6 NLRX1 PACSIN1 PSMB7 RP11-373D23.3 SF3B1 SLC22A5 SUOX TRAF3 TUFM U91328.19 WBP1L ZBTB38
Pulse rate, automated reading 0.98 5 1 3.0 0.64 2.5e-01 PACSIN1 SIK2 SUOX U91328.19 ZBTB38
Alcohol intake frequency. 1.36 4 1 3.0 -0.60 4.0e-01 MANBA NAGLU SUOX TUFM
Comparative height size at age 10 2.00 13 8 24.2 -0.14 6.4e-01 C1orf43 CCDC116 EVI5 IQGAP1 IRF1 MPHOSPH9 NLRX1 PACSIN1 RP5-1115A15.1 SLC22A5 TUFM WBP1L ZBTB38
Suffer from 'nerves' 0.92 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Overall health rating 1.02 2 0 0.0 0.00 1.0e+00 PACSIN1 SF3B1
Medication: Aspirin 1.43 1 0 0.0 0.00 1.0e+00 SIK2
Knee pain experienced in last month 1.69 4 0 0.0 0.98 3.4e-03 DEXI MPHOSPH9 RP11-396B14.2 RP11-876N24.4
Hypertension (Self-reported) 1.57 9 4 12.1 -0.21 5.8e-01 ADAM1A CLIC4 MPI NDUFAF1 OVOL1 POLI RP5-1115A15.1 SIK2 SUOX
Illnesses of father: Heart disease 1.46 2 0 0.0 0.00 1.0e+00 SIK2 SMAD3
Forced expiratory volume in 1-second (FEV1), predicted 1.63 4 2 6.1 -0.19 8.1e-01 PACSIN1 SLC22A5 WBP1L ZBTB38
Whole body fat-free mass 2.22 20 12 36.4 -0.23 3.1e-01 EFEMP2 FOXO1 GLS2 IRF1 MPHOSPH9 NDUFAF1 NEK6 NLRX1 PACSIN1 PSMB7 RP11-373D23.3 SF3B1 SLC22A5 SPPL3 SUOX TRAF3 TUFM U91328.19 WBP1L ZBTB38
Leg fat-free mass (right) 1.99 15 10 30.3 -0.33 2.4e-01 EFEMP2 IRF1 MPHOSPH9 MPI NAGLU NLRX1 PACSIN1 RP11-373D23.3 SLC22A5 SPPL3 SUOX TRAF3 TUFM U91328.19 ZBTB38
Arm fat percentage (left) 1.30 6 6 18.2 -0.62 1.8e-01 NAGLU PACSIN1 RP5-1115A15.1 TRAF3 TUFM U91328.19
Average weekly red wine intake 1.41 1 0 0.0 0.00 1.0e+00 MPI
Loneliness, isolation 1.02 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Ever had bowel cancer screening 1.34 1 0 0.0 0.00 1.0e+00 SIK2
Diabetes diagnosed by doctor 1.16 1 0 0.0 0.00 1.0e+00 NAGLU
Qualifications: nursing, teaching 0.93 1 0 0.0 0.00 1.0e+00 MPHOSPH9
Mouth/teeth dental problems: Mouth ulcers 2.34 1 0 0.0 0.00 1.0e+00 NFKB1
Asthma (self-reported) 15.64 53 40 121.2 0.95 5.3e-34 AC114730.7 AHI1 BACH2 C1orf43 CD247 CLEC16A D2HGDH DEXI FAM18A FBXO18 GLDC IL18R1 IL18RAP IL1RL2 IRF1 JAZF1 KIAA1109 KIF3A KRT222 LINGO4 LRRC32 NAGLU NDFIP1 NDUFAF1 NLRX1 ORMDL3 POLI PPOX PRKRIR RANBP6 RMI2 RP11-396B14.2 RP11-876N24.4 RP11-876N24.5 RP5-1115A15.1 S100A11 SIK2 SLC22A5 SLC25A46 SMAD3 SPATA5 SPPL3 STAT6 STMN3 SUOX THRA TLR1 TMEM232 TNFSF18 TSLP UHRF2 WDR36 ZBTB38
Medication: Aspirin 1.45 1 0 0.0 0.00 1.0e+00 SIK2
Illnesses of father: None of the above (group 1) 1.32 1 0 0.0 0.00 1.0e+00 SMAD3
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.55 2 0 0.0 0.00 1.0e+00 ORMDL3 U91328.19
Whole body water mass 2.21 19 12 36.4 -0.18 4.5e-01 EFEMP2 GLS2 IRF1 MPHOSPH9 NDUFAF1 NEK6 NLRX1 PACSIN1 PSMB7 RP11-373D23.3 SF3B1 SLC22A5 SPPL3 SUOX TRAF3 TUFM U91328.19 WBP1L ZBTB38
Leg predicted mass (right) 2.00 16 10 30.3 -0.27 3.2e-01 EFEMP2 GLS2 IRF1 MPHOSPH9 MPI NAGLU NLRX1 PACSIN1 RP11-373D23.3 SLC22A5 SPPL3 SUOX TRAF3 TUFM U91328.19 ZBTB38
Arm fat mass (left) 1.60 11 7 21.2 -0.46 1.5e-01 EFEMP2 FOXO1 NAGLU NLRX1 PACSIN1 RP5-1115A15.1 SUOX TRAF3 TUFM U91328.19 ZBTB38
Number of self-reported non-cancer illnesses 3.21 9 2 6.1 0.97 9.3e-06 D2HGDH DEXI IL1RL2 LRRC32 ORMDL3 RGS14 RP11-396B14.2 RP11-876N24.4 STMN3
Miserableness 1.19 2 0 0.0 0.00 1.0e+00 ORMDL3 RP5-1115A15.1
Medication: Blood pressure 1.56 5 2 6.1 0.17 7.9e-01 MPI NDUFAF1 OVOL1 SIK2 SLC22A5
Ever smoked 1.22 1 0 0.0 0.00 1.0e+00 WBP1L
Basal metabolic rate 2.21 19 11 33.3 -0.36 1.2e-01 EFEMP2 FOXO1 IRF1 MPHOSPH9 MPI NAGLU NLRX1 PACSIN1 PSMB7 RP11-373D23.3 SF3B1 SLC22A5 SPPL3 SUOX TRAF3 TUFM U91328.19 WBP1L ZBTB38
Leg fat percentage (left) 1.49 8 6 18.2 -0.21 6.2e-01 KRT222 MPHOSPH9 PACSIN1 RP5-1115A15.1 STMN3 TRAF3 TUFM U91328.19
Arm fat-free mass (left) 2.39 17 14 42.4 -0.30 2.3e-01 EFEMP2 FOXO1 IRF1 MPHOSPH9 NEK6 NLRX1 PACSIN1 PSMB7 RP11-373D23.3 SF3B1 SLC22A5 SUOX TRAF3 TUFM U91328.19 WBP1L ZBTB38
Number of operations (self-reported) 2.00 5 0 0.0 0.47 3.4e-01 DEXI NEK6 PSMB7 RP11-876N24.4 RP5-1115A15.1
Irritability 1.00 1 0 0.0 0.00 1.0e+00 MRPS33
Ever had prostate specific antigen (PSA) test 1.67 1 0 0.0 0.00 1.0e+00 ZBTB38
Diastolic blood pressure, automated reading 1.81 9 6 18.2 -0.01 9.7e-01 ADAM1A CLIC4 MPHOSPH9 MPI NDUFAF1 RP5-1115A15.1 SLC15A2 STMN3 SUOX
Myopia 1.37 1 0 0.0 0.00 1.0e+00 STAT6
Vascular/heart problems diagnosed by doctor 1.62 8 5 15.2 0.12 7.7e-01 ADAM1A MPI NDUFAF1 RP5-1115A15.1 SIK2 SLC22A5 SMAD3 SUOX
Pain experienced in last month 1.27 1 1 3.0 0.00 1.0e+00 SUOX
Impedance of whole body 1.50 12 7 21.2 0.48 9.5e-02 EFEMP2 JAZF1 LCLAT1 LRRC32 MANBA NAGLU NEK6 NLRX1 PACSIN1 PSMB7 SF3B1 SUOX
Leg fat mass (left) 1.76 13 8 24.2 -0.29 3.4e-01 EFEMP2 MPI NAGLU NLRX1 PACSIN1 RP11-373D23.3 RP5-1115A15.1 STMN3 SUOX TRAF3 TUFM U91328.19 ZBTB38
Arm predicted mass (left) 2.40 16 14 42.4 -0.30 2.5e-01 EFEMP2 FOXO1 MPHOSPH9 NEK6 NLRX1 PACSIN1 PSMB7 RP11-373D23.3 SF3B1 SLC22A5 SUOX TRAF3 TUFM U91328.19 WBP1L ZBTB38

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 21 0.602 2.15
GTEx Adipose Visceral Omentum 14 0.688 2.19
GTEx Adrenal Gland 8 0.549 2.05
GTEx Artery Aorta 16 0.537 2.13
GTEx Artery Coronary 5 0.423 2.14
GTEx Artery Tibial 21 0.558 2.15
GTEx Brain Caudate basal ganglia 3 0.326 1.95
GTEx Brain Cerebellar Hemisphere 10 0.672 2.12
GTEx Brain Cerebellum 11 0.555 2.08
GTEx Brain Cortex 9 0.870 2.28
GTEx Brain Frontal Cortex BA9 7 0.758 2.17
GTEx Brain Hippocampus 2 0.382 1.85
GTEx Brain Hypothalamus 4 0.678 2.19
GTEx Brain Nucleus accumbens basal ganglia 8 0.925 2.25
GTEx Brain Putamen basal ganglia 6 0.962 2.19
GTEx Breast Mammary Tissue 16 0.811 2.31
GTEx Breast Mammary Tissue (Male) 8 0.671 2.23
GTEx Breast Mammary Tissue (Female) 13 0.791 2.30
GTEx Cells EBV-transformed lymphocytes 7 0.492 1.98
GTEx Cells Transformed fibroblasts 33 0.786 2.24
GTEx Colon Sigmoid 10 0.684 2.18
GTEx Colon Transverse 15 0.727 2.20
GTEx Esophagus Gastroesophageal Junction 10 0.692 2.23
GTEx Esophagus Mucosa 21 0.633 2.29
GTEx Esophagus Muscularis 23 0.712 2.20
GTEx Heart Atrial Appendage 7 0.443 2.16
GTEx Heart Left Ventricle 5 0.327 1.87
GTEx Liver 4 0.558 2.16
GTEx Lung 22 0.766 2.09
GTEx Muscle Skeletal 16 0.554 2.10
GTEx Nerve Tibial 22 0.509 2.10
GTEx Ovary 7 0.771 2.12
GTEx Pancreas 15 0.919 2.26
GTEx Pituitary 9 0.807 2.05
GTEx Prostate 5 0.599 2.09
GTEx Skin Not Sun Exposed Suprapubic 21 0.854 2.20
GTEx Skin Sun Exposed Lower leg 24 0.659 2.14
GTEx Small Intestine Terminal Ileum 4 0.868 1.97
GTEx Spleen 12 0.850 2.22
GTEx Stomach 7 0.481 2.01
GTEx Testis 23 0.729 2.27
GTEx Thyroid 33 0.825 2.22
GTEx Uterus 5 0.882 2.18
GTEx Vagina 2 0.315 2.13
GTEx Whole Blood 17 0.853 2.30
METSIM Adipose 30 0.651 2.22
NTR Blood 21 0.874 2.31
ROSMAP Brain Pre-frontal Cortex 24 0.547 2.16
YFS Blood 35 0.758 2.39
CommonMind Brain Pre-frontal Cortex 27 0.502 2.12
TCGA Breast Tumor 8 1.043 2.52
TCGA Breast Normal 22 0.523 2.02
TCGA Ovarian Tumor 7 0.240 1.72
TCGA Prostate Tumor 28 0.809 2.21